Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Otogenetics Hearing Loss and Deafness Multi-Gene NGS Panel Otogenetics United States | 123 | 129 |
|
LOXHD1 - NGS including CNV analysis Centogene US, LLC - The Rare Disease Company United States | 1 | 1 |
|
Centogene US, LLC - The Rare Disease Company United States | 316 | 314 |
|
Centogene US, LLC - The Rare Disease Company United States | 203 | 194 |
|
Centogene AG - the Rare Disease Company Germany | 316 | 314 |
|
LOXHD1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Carrier Screening Guidelines-Based Panel Ambry Genetics United States | 199 | 165 |
|
Carrier Screening Ashkenazi Jewish Panel Ambry Genetics United States | 51 | 48 |
|
Centogene AG - the Rare Disease Company Germany | 203 | 194 |
|
Invitae Corneal Dystrophies Panel Invitae United States | 65 | 33 |
|
Invitae Comprehensive Deafness Panel Invitae United States | 405 | 219 |
|
Molecular Otolaryngology and Renal Research Laboratories University of Iowa Hospital and Clinics United States | 288 | 218 |
|
Intergen Genetic Diagnosis and Research Centre Turkey | 1 | 1 |
|
Invitae Comprehensive Carrier Screen without X-linked Disorders Invitae United States | 228 | 279 |
|
Invitae Comprehensive Carrier Screen Invitae United States | 247 | 301 |
|
Hereditary Hearing Loss and Deafness Panel PreventionGenetics United States | 356 | 211 |
|
PreventionGenetics United States | 40 | 27 |
|
Deafness, Autosomal Recessive 77 (DFNB77) via the LOXHD1 Gene PreventionGenetics United States | 1 | 1 |
|
Corneal dystrophy panel. NGS panel of 27 genes. Genologica Medica Spain | 44 | 27 |
|
Non-syndromic hearing loss panel. 95-gene NGS panel. Genologica Medica Spain | 146 | 94 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.